CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		289,093
Beginning balance at Dec. 31, 2022	$ 1,051,818	$ 3	$ 4,562,319	$ (7,431)	$ (3,503,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		19
Issuance of common stock upon exercise of stock options	6		6
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		1,423
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(12,845)		(12,845)
Stock-based compensation	51,208		51,208
Other comprehensive income (loss)	2,919			2,919
Net loss	(42,664)				(42,664)
Ending balance (in shares) at Mar. 31, 2023		290,535
Ending balance at Mar. 31, 2023	1,050,442	$ 3	4,600,688	(4,512)	(3,545,737)
Beginning balance (in shares) at Dec. 31, 2023		296,695
Beginning balance at Dec. 31, 2023	$ 1,072,262	$ 3	4,713,522	(754)	(3,640,509)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	32	32
Issuance of common stock upon exercise of stock options	$ 10		10
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes (in shares)		1,773
Issuance of common stock upon vesting and settlement of restricted stock units, net of shares withheld for taxes	(22,706)		(22,706)
Stock-based compensation	52,410		52,410
Other comprehensive income (loss)	(520)			(520)
Net loss	(23,325)				(23,325)
Ending balance (in shares) at Mar. 31, 2024		298,500
Ending balance at Mar. 31, 2024	$ 1,078,131	$ 3	$ 4,743,236	$ (1,274)	$ (3,663,834)